Thomas C. Beadnell

1.4k total citations · 1 hit paper
19 papers, 1.0k citations indexed

About

Thomas C. Beadnell is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Thomas C. Beadnell has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Thomas C. Beadnell's work include Cancer, Hypoxia, and Metabolism (6 papers), Mitochondrial Function and Pathology (5 papers) and Cancer-related Molecular Pathways (4 papers). Thomas C. Beadnell is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Mitochondrial Function and Pathology (5 papers) and Cancer-related Molecular Pathways (4 papers). Thomas C. Beadnell collaborates with scholars based in United States, United Kingdom and Australia. Thomas C. Beadnell's co-authors include Danny R. Welch, Kathryn L. Schwertfeger, Adam D. Scheid, Jaclyn Essig, Branden S. Moriarity, Yasuhiko Kawakami, Wuming Gong, York Marahrens, David A. Largaespada and George M. Otto and has published in prestigious journals such as Nature, PLoS ONE and Cancer Research.

In The Last Decade

Thomas C. Beadnell

17 papers receiving 1.0k citations

Hit Papers

PVT1 dependence in cancer with MYC copy-number increase 2014 2026 2018 2022 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PVT1 dependence in cancer with MYC copy-number increase
    2014 561 citations Branden S. Moriarity, Wuming Gong et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas C. Beadnell United States 13 776 594 174 90 55 19 1.0k
Leire Gárate Spain 23 1.2k 1.6× 573 1.0× 154 0.9× 106 1.2× 48 0.9× 32 1.5k
Min Pan United States 14 644 0.8× 504 0.8× 218 1.3× 118 1.3× 45 0.8× 22 912
Hongming Song China 20 750 1.0× 617 1.0× 141 0.8× 63 0.7× 59 1.1× 38 1.0k
Daniela D’Angelo Italy 18 743 1.0× 578 1.0× 93 0.5× 66 0.7× 58 1.1× 30 1.0k
Yingduan Cheng China 19 815 1.1× 386 0.6× 171 1.0× 73 0.8× 122 2.2× 33 1.1k
Yi Sang China 19 885 1.1× 433 0.7× 220 1.3× 98 1.1× 108 2.0× 44 1.1k
Lise Lotte Christensen Denmark 9 687 0.9× 546 0.9× 123 0.7× 55 0.6× 50 0.9× 16 858
Hong‐Li Jiao China 18 821 1.1× 605 1.0× 143 0.8× 47 0.5× 66 1.2× 25 978

Countries citing papers authored by Thomas C. Beadnell

Since Specialization
Citations

This map shows the geographic impact of Thomas C. Beadnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Beadnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Beadnell more than expected).

Fields of papers citing papers by Thomas C. Beadnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Beadnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Beadnell. The network helps show where Thomas C. Beadnell may publish in the future.

Co-authorship network of co-authors of Thomas C. Beadnell

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Beadnell. A scholar is included among the top collaborators of Thomas C. Beadnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Beadnell. Thomas C. Beadnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Groves, Christopher J., Michael A. Linden, Ahmad Al‐Attar, et al.. (2025). Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories. Cytometry Part B Clinical Cytometry. 110(1). 11–21.
2.
Beadnell, Thomas C., et al.. (2024). Using Spectral Flow Cytometry for CAR T-Cell Clinical Trials: Game Changing Technologies Enabling Novel Therapies. International Journal of Molecular Sciences. 25(19). 10263–10263.
3.
Beadnell, Thomas C., et al.. (2023). Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity. Cells. 12(10). 1374–1374. 6 indexed citations
4.
Nathanson, David, Michael Detmar, Timothy P. Padera, et al.. (2021). Mechanisms of breast cancer metastasis. Clinical & Experimental Metastasis. 39(1). 117–137. 42 indexed citations
5.
Young, Eric D., Sharon Manley, Thomas C. Beadnell, et al.. (2020). Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5. British Journal of Cancer. 124(1). 166–175. 13 indexed citations
6.
Scheid, Adam D., Thomas C. Beadnell, & Danny R. Welch. (2020). Roles of mitochondria in the hallmarks of metastasis. British Journal of Cancer. 124(1). 124–135. 77 indexed citations
7.
Brinker, Amanda E., Carolyn J. Vivian, Thomas C. Beadnell, et al.. (2019). Mitochondrial Haplotype of the Host Stromal Microenvironment Alters Metastasis in a Non-cell Autonomous Manner. Cancer Research. 80(5). 1118–1129. 17 indexed citations
8.
Beadnell, Thomas C., Cori E. Fain, Carolyn J. Vivian, et al.. (2019). Mitochondrial genetics cooperate with nuclear genetics to selectively alter immune cell development/trafficking. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(5). 165648–165648. 9 indexed citations
9.
Scheid, Adam D., Thomas C. Beadnell, & Danny R. Welch. (2019). The second genome: Effects of the mitochondrial genome on cancer progression. Advances in cancer research. 142. 63–105. 14 indexed citations
10.
Beadnell, Thomas C., Lucia Borriello, Jessica L. Christenson, et al.. (2019). Meeting report: Metastasis Research Society (MRS) 17th Biennial conference and associated Young Investigator Satellite Meeting (YISM) on cancer metastasis. Clinical & Experimental Metastasis. 36(2). 119–137. 1 indexed citations
11.
Beadnell, Thomas C., Kelsey W. Nassar, Brian P. Danysh, et al.. (2018). Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer. Oncogenesis. 7(2). 23–23. 42 indexed citations
12.
Beadnell, Thomas C., Adam D. Scheid, Carolyn J. Vivian, & Danny R. Welch. (2018). Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer. Cancer and Metastasis Reviews. 37(4). 615–632. 34 indexed citations
13.
Beadnell, Thomas C., et al.. (2017). Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer. Oncotarget. 8(61). 103014–103031. 10 indexed citations
14.
Beadnell, Thomas C., Qiong Zhou, Kelsey E. Wuensch, et al.. (2016). The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer. Molecular Cancer Therapeutics. 15(8). 1952–1963. 17 indexed citations
15.
Avdulov, Svetlana, Jeremy Herrera, Karen Smith, et al.. (2014). eIF4E Threshold Levels Differ in Governing Normal and Neoplastic Expansion of Mammary Stem and Luminal Progenitor Cells. Cancer Research. 75(4). 687–697. 13 indexed citations
16.
Moriarity, Branden S., Wuming Gong, Ryutaro Akiyama, et al.. (2014). PVT1 dependence in cancer with MYC copy-number increase. Nature. 512(7512). 82–86. 561 indexed citations breakdown →
17.
Bohrer, Laura R., Pavlina Chuntova, Thomas C. Beadnell, et al.. (2013). Activation of the FGFR–STAT3 Pathway in Breast Cancer Cells Induces a Hyaluronan-Rich Microenvironment That Licenses Tumor Formation. Cancer Research. 74(1). 374–386. 59 indexed citations
18.
Stone, Matthew D., et al.. (2012). Fibroblast Growth Factor Receptor 1 Activation in Mammary Tumor Cells Promotes Macrophage Recruitment in a CX3CL1-Dependent Manner. PLoS ONE. 7(9). e45877–e45877. 62 indexed citations
19.
Bell, Jason, et al.. (2010). Duration of Expression and Activity of Sleeping Beauty Transposase in mouse liver following hydrodynamic DNA delivery. Molecular Therapy. 18(10). 1796–1802. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leire Gárate Breakdown of academic impact, for papers by Min Pan Breakdown of academic impact, for papers by Hongming Song Breakdown of academic impact, for papers by Daniela D’Angelo Breakdown of academic impact, for papers by Yingduan Cheng Breakdown of academic impact, for papers by Yi Sang Breakdown of academic impact, for papers by Lise Lotte Christensen Breakdown of academic impact, for papers by Hong‐Li Jiao
Rankless by CCL
2026